International Innovative Oncology Companies Showcase

2020 China BioMed Innovation and Investment Conference

September 2020

Suzhou, China

China BioMed Innovation and Investment Conference

China BioMed Innovation and Investment Conference (CBIIC) is an annual grand conference to promote the communication between pharmaceutical industry and investment industry, established and initiated by China Pharmaceutical Innovation and Research Development Association (PhIRDA) in 2016. 

 

CBIIC was successively co-hosted by Securities Association of China (SAC), China Association for Medical Devices Industry (CAMDI), Hong Kong Exchanges and Clearing Limited (HKEX) and Chinese Hospital Association (CHA), Research and Development International (RDI) from 2016 to 2019.

PhIRDA will host the 2020 CBIIC on September 27-29 in
Suzhou Industrial Park, China. The National Foundation for Cancer Research will co-host the International Innovative Oncology Companies Showcase session with PhIRDA. The showcase session will be conducted in a virtual format due to the impact of COVID-19 pandemic. One-on-One partnering service will be provided for participants.

Conference Access*
  • > 1,500 investment institutions

  • > 2,100 biomedical companies

  • > 10,000 screened conference attendees, including Chinese and other government, industry, scientific and hospital decision makers

  • >20 parallel sessions & forums, where 33 new drugs made global first clinical trial data release and 450 innovative projects made roadshows​​

* Based on 2019 CBIIC attendance figures

International Innovative Oncology Companies Showcase
 
September 2020
Virtual Event

A special opportunity to showcase the international oncology technology companies to leading Chinese and global biomedical investors and collaborators.

 

  • For the fourth year in a row, the National Foundation for Cancer Research (NFCR) has been co-organizing the special showcase within the Asia's most significant annual biomedical industry investment gathering, the China BioMed Innovation and Investment Conference (CBIIC)

  • Select U.S. or other non-Chinese oncology technology companies will be highlighted in a virtual session within CBIIC, featuring 20-30 minute pitches to the audience attending 2020 CBIIC. Total conference is forecast to have over 10,000 attendees.

  • Presenting oncology technology companies will also avail access to the partnering oppor offered by NFCR and CBIIC. 

Prior Oncology Showcase Highlights

INTERNATIONAL SHOWCASE SPONSORS

AIM-HI logo.png
AFCR FINAL LOGO_new.png

© Copyright 2020 National Foundation for Cancer Research. All Rights Reserved.